23 May 2013
Keywords: generex, begins, dosing, pivotal, ph, iii, oral-lyn
Article | 21 July 2008
The USA's Generex Biotechnology has initiated dosing of over one hundred patients in the pivotal Phase III clinical trial of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 July 2008
22 May 2013
© 2013 thepharmaletter.com